Acute malignant myelosclerosis. Evidence for a panmyelotic disturbance of cellular differentiation

Targeted-therapy in advanced renal cell carcinoma.

Current medicinal chemistry·2011

Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study.

In vivo (Athens, Greece)·2007

Thyroid metastases from colon cancer case report in a long term survivor.

Journal of experimental & clinical cancer research : CR·2006

Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.

Journal of experimental & clinical cancer research : CR·2006

Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.

Journal of chemotherapy (Florence, Italy)·2005

Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone.

Journal of chemotherapy (Florence, Italy)·2005

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Haematologica·2026

Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Haematologica·2026

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Haematologica·2026

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Haematologica·2026

Central nervous system management remains an evidence gap in first-line tagraxofusp therapy for blastic plasmacytoid dendritic cell neoplasm. Comment on: "First-line tagraxofusp leads to durable responses and prolonged survival in adults with blastic plasmacytoid dendritic cell neoplasm regardless of fitness level".

Haematologica·2026

Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.

Haematologica·2026

Ex vivo Evaluation of Live-MB2 and CX-2 Biotic Strains on Inflammatory and Barrier-Related Biomarkers in a Human Skin Atopic Dermatitis-Like Model.

Clinical, cosmetic and investigational dermatology·2026

Multifocal Necrotizing Fasciitis of the Bilateral Chest Wall and Contralateral Lower Limb in a Patient With Diabetes: A Case Report.

Cureus·2026

A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion.

Cell death & disease·2026

A tiered tissue-based framework for diagnosing invasive fungal diseases: Integrating histopathology with targeted and metagenomic sequencing.

Diagnostic microbiology and infectious disease·2026

Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis.

Cancer treatment and research communications·2026

Multi-habitat radiomics on T2-FS MRI for identifying spatial patterns of axial spondyloarthritis-associated bone marrow edema.

Clinical rheumatology·2026

Related Experiment Videos

Acute malignant myelosclerosis. Evidence for a panmyelotic disturbance of cellular differentiation

Related Concept Videos

Targeted-therapy in advanced renal cell carcinoma.

Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study.

Thyroid metastases from colon cancer case report in a long term survivor.

Tyrosine kinase inhibitor imatinib mesylate as anticancer agent for advanced ocular melanoma expressing immunoistochemical C-KIT (CD 117): preliminary results of a compassionate use clinical trial.

Hepatic intra-arterial chemotherapy (HIAC) of high dose mitomycin and epirubicin combined with caval chemofiltration versus prolonged low doses in liver metastases from colorectal cancer: a prospective randomized clinical study.

Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone.

First line asciminib in chronic myeloid leukemia: a quest for the "Holy Grail" of tolerability.

Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".

Successful treatment of systemic juvenile xanthogranuloma with an ABL2::GAB2 fusion using dasatinib after failure of conventional chemotherapy and MEK inhibition.

Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.

Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.

Ex vivo Evaluation of Live-MB2 and CX-2 Biotic Strains on Inflammatory and Barrier-Related Biomarkers in a Human Skin Atopic Dermatitis-Like Model.

Multifocal Necrotizing Fasciitis of the Bilateral Chest Wall and Contralateral Lower Limb in a Patient With Diabetes: A Case Report.

A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion.

A tiered tissue-based framework for diagnosing invasive fungal diseases: Integrating histopathology with targeted and metagenomic sequencing.

Clinical application of serum Mac-2-binding protein glycosylation isomer in the diagnosis of liver fibrosis: a meta-analysis.

Multi-habitat radiomics on T2-FS MRI for identifying spatial patterns of axial spondyloarthritis-associated bone marrow edema.

Related Experiment Videos

Acute malignant myelosclerosis. Evidence for a panmyelotic disturbance of cellular differentiation

Related Concept Videos

Related Articles